As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...

Hims & Hers and GoodRx are reshaping virtual care, but which one leads in platform strategy and patient engagement? Let's dive in.

In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 1483.33 with a total volume of 6,561.00.

Hims & Hers shows platform expansion, verticalization, new Labs offerings, slower FCF growth and strong long-term revenue ...

Curious whether Hims & Hers Health is undervalued, overhyped, or a hidden gem? Let’s break down what recent moves and news might mean for today’s investors. The stock has delivered a wild ride lately, ...

Within the healthcare space, one company that combines fundamental safety with the high growth rates typically found in ...

Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from ...

The investment seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of Hims & Hers Health, Inc. (NYSE: HIMS). The fund ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

In recent discussions surrounding market investments, a distinct focus has emerged on the importance of a value investing approach, emphasizing an owner’s mindset and a long-term perspective. This ...